2023
2021
- Abdrabou AMM, Bajwa ZUH, Halfmann A, Mellmann A, Nimmesgern A,Margardt L, Bischoff M, von Müller L, Gärtner BC, Berger FK: Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019.
- A Baktash, J Corver, C Harmanus, W K Smits, W Fawley, M H Wilcox, N Kumar, D W Eyre, A Indra, A Mellmann, E J Kuijper: COMPARISON OF WHOLE GENOME SEQUENCE-BASED METHODS AND PCR RIBOTYPING FOR SUBTYPING OF Clostridioides difficile
2020
- Davies K, Lawrence J, Berry C, Davis G, Yu H, Cai B, Gonzalez E, Prantner I, Kurcz A, Macovei I, Pituch H, Nováková E, Nyč O, Gärtner BC, Berger FK, Oleastro M, Cornely OA, Vehreschild M, Pedneault L, Wilcox M: Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID).
- Konstantinović J, Yahiaoui S, Alhayek A, Haupenthal J, Schönauer E, Andreas A, Kany A, Mueller R, Köhnke J, Berger FK, Bischoff M, Hartmann R, Brandstetter H, Hirsch A: N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium Collagenases.
2019
2018
2017
- D
avies K, Davis G, Barbut F, Eckert C, Petrosillo N, Pisapia R, Reigadas E, Emilio Bouza, Berger F, Herrmann M, Wilcox MH: Multivariate analysis of factors affecting Clostridium difficile infection rates; the more you look, the more you find, but should you believe what you see?. - Berger F, Bischoff M, Strauß C, von Müller L, Gärtner B.: Auftreten von Clostridium difficile Ribotyp 176 in Deutschland.
- Färber J, Illiger S, Berger F, Gärtner B, von Müller L, Lohmann C.H, Bauer K, Grabau C, Zibolka S, Schlüter D, Geginat G: Management of a Cluster of Clostridium difficile infections among patients with osteoarticular infections.
- Berger F: Clostridium difficile: Routine diagnostics in the medical laboratory.
2016
- von Müller L.:Aktuelles zu Clostridium-difficile-Infektionen (New aspects on Clostridium difficile infection).
- Davies KA, Davis GL, Barbut F, Eckert C, Petrosillo N, Pisapia R, Reigadas-Ramirez E, Bouza E, Berger F, Herrmann M, Wilcox MH.: Seasonality of C. difficile Infection (CDI) Case Rates: Myth or Reality?.
- Davies KA, Davis GL, Barbut F, Eckert C, Spigaglia P, Barbanti F, Herrmann M, Berger F, Bouza E, Reigadas-Ramirez E, Wilcox MH.: Adverse outcomes for missed cases of CDI; results from retrospective data collection on patients with samples received during the EUropean, multi-centre, prospective bi-annual point prevalence study of CLostridium difficile Infection in hospitalised patients with Diarrhoea (EUCLID2).
- Davies KA, Lawrence J, Berry C, Davis GL, Yu H, Cai B, Gonzalez E, Prantner I, Kurcz A, Macovei I, Pituch H, Nováková E, Nyč O, Herrmann M, Berger F, Cornely O, Vehreschild M, Pedneault L, Wilcox MH.: Observational Study of Risk factors for Clostridium difficile Infection in Hospitalised Patients with Infective Diarrhoea (ORCHID): Consistency of Risk Factors.
2015
- Weichert S, Simon A, von Müller L, Adam R, Schroten H.: Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter.
- S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple.
- Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences.
- Molecular and culture-based diagnosis of Clostridium difficile isolates from Côte d'Ivoire after prolonged storage at disrupted cold chain conditions.
- Combined stool-based multiplex PCR and microscopy for enhanced pathogen detection in patients with persistent diarrhoea and asymptomatic controls from Côte d'Ivoire.
- Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons.
- Clostridium difficile infections among adults and children in Mwanza/Tanzania is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?
2014
- Schwer verlaufende Clostridium-difficile-Infektionen: IfSG-Surveillancedaten von 2013.
- Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
- Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID).
